文献速递神经免疫认知障碍与痴呆

血清神经丝轻链对临床孤立综合征患者的预后价值

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes.
PubMed 文献 · Neurology · 2019-01-11

该研究回顾性分析2000至2015年间222例首次脱髓鞘事件患者,评估基线血清神经丝轻链(NfL)对临床确诊多发性硬化(CDMS)和McDonald 2017多发性硬化的预后作用。中位随访100.6个月,2年时20%发展为CDMS、63.5%发展为2017 MS;低及极低NfL水平者CDMS风险降低三倍、2017 MS风险降低两倍,调整寡克隆带等预后因素后结果不变。

要点

  • 血清NfL可预测临床孤立综合征患者向多发性硬化的转化。
  • 低及极低NfL水平分别与CDMS风险降低三倍和2017 MS风险降低两倍相关。
  • NfL与基线残疾相关,但与随访残疾无关。

核心结论

  • 血清NfL对临床孤立综合征患者转化为多发性硬化具有预后价值。
  • NfL可能具有双重生化标志物角色:峰值水平反映严重炎症活动,稳态水平反映神经退行性和慢性炎症过程。

研究设计与样本

  • 回顾性分析2000至2015年间就诊于神经内科的首次脱髓鞘事件患者数据。
  • 共纳入222例患者,平均随访100.6个月。
  • 评估基线血清NfL以及脑脊液、MRI和临床数据。

主要发现

  • 2年时45例(20%)发展为CDMS,141例(63.5%)发展为McDonald 2017 MS。
  • 血清NfL中位数22.0 pg/mL(四分位距11.6-40.4 pg/mL),在近期复发及基线MRI T2病灶和高钆增强病灶多的患者中明显升高。
  • 低及极低NfL水平者CDMS风险降低三倍、2017 MS风险降低两倍。
  • 调整寡克隆带、钆增强病灶和基线MRI高T2病灶负荷等既定预后因素后结果不变。
  • NfL与基线残疾相关,但与随访残疾无关。

临床怎么用

  • 血清NfL可作为临床孤立综合征患者多发性硬化转化风险的预后评估工具。
  • 解读NfL水平时需结合近期复发和基线MRI炎症活动情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the prognostic role of serum neurofilament light chains (NfL) for clinically defined multiple sclerosis (CDMS) and McDonald 2017 multiple sclerosis (MS) in patients with clinically isolated syndromes (CIS). METHODS: We retrospectively analyzed data of patients admitted to our neurologic department between 2000 and 2015 for a first demyelinating event. We evaluated baseline serum NfL in addition to CSF, MRI, and clinical data. RESULTS: Among 222 patients who were enrolled (mean follow-up 100.6 months), 45 patients (20%) developed CDMS and 141 patients (63.5%) developed 2017 MS at 2 years. Serum NfL (median 22.0, interquartile range 11.6-40.4 pg/mL) was noticeably increased in patients with a recent relapse, with a high number of T2 and gadolinium-enhancing lesions at baseline MRI. Serum NfL was prognostic for both CDMS and McDonald 2017 MS, with a threefold and a twofold respective reduction in CDMS and 2017 MS risk in those patients with low and extremely low levels of NfL. The results remained unchanged subsequent to adjustment for such established MS prognostic factors as oligoclonal bands, Gd-enhancing lesions, and a high T2 lesion load at baseline MRI. NfL was associated with disability at baseline but not at follow-up. CONCLUSIONS: Serum NfL have a prognostic value for CIS patient conversion to MS. NfL might play a twin role as biomarker in MS as peak level measurements can act as a quantitative marker of serious inflammatory activity, while steady-state levels can be a reflection of neurodegenerative and chronic inflammatory processes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Dalla Costa G, Martinelli V, Sangalli F, et al. Prognostic value of serum neurofilaments in patients with clinically isolated syndromes. Neurology. 2019. PMID: 30635483. doi:10.1212/WNL.0000000000006902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。